Table 1.
Baseline Patient and Procedure Characteristics
| All | MTURB | BTURB | p | |
|---|---|---|---|---|
| n | 586 | 207 | 379 | |
| Mean age in years (range) | 69 (22–101) | 69 (22–101) | 69 (29–100) | 0.940 |
| Women, n (%) | 180 (31) | 60 (29) | 120 (32) | 0.500 |
| Mean ASA score | 2.7 | 2.63 | 2.74 | 0.011 |
| TURB per patient during study period, n (%) | ||||
| 1 | 320 (74.9) | |||
| 2 | 75 (17.6) | |||
| ≥3 | 32 (7.5) | |||
| Preoperative anticoagulant or antiplatelet medication, n (%) | 232 (40) | 73 (35) | 159 (42) | 0.133 |
| Size of bladder tumor resection, n (%) | 0.629 | |||
| Small: 0.5–2.0 cm | 265 (45) | 97 (47) | 168 (44) | |
| Medium: 2.0–5.0 cm | 215 (37) | 70 (34) | 145 (38) | |
| Large: >5.0 cm | 104 (18) | 38 (19) | 66 (17) | |
| Complete resection, n (%) | 540 (92) | 193 (93) | 347 (92) | 0.523 |
| Muscle invasion, n (%) | 0.183 | |||
| Noninvasive | 498 (85) | 170 (82) | 328 (87) | |
| Muscle Invasive | 88 (15) | 37 (18) | 51 (13) | |
| Pathology | 0.341 | |||
| Benign, n (%) | 79 (13.9) | 31 (15.6) | 48 (13.0) | |
| PUNLMP | 26 (4.6) | 12 (6.0) | 14 (3.8) | |
| Low-grade urothelial carcinoma | 179 (31.5) | 62 (31.1) | 117 (31.6) | |
| High-grade urothelial carcinoma | 222 (39.0) | 72 (36.2) | 150 (40.5) | |
| Planned postoperative urethral catheter, n (%) | 288 (49.1) | 122 (58.9) | 166 (43.8) | 0.0005 |
ASA = American Society of Anesthesiology; BTURB = bipolar transurethral resection of bladder tumor; MTURB = monopolar transurethral resection of bladder tumor; PUNLMP = papillary urothelial neoplasm of low malignant potential.